Related Experiment Video
Updated: Sep 19, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Efficacy and Safety of Prothrombin Complex Concentrate Compared to Fresh Frozen Plasma in Cardiac Surgery: A
Muhammad Abdullah Ali1, Abdullah Afridi1, Furqan Ahmad Sethi1
1From the Department of Medicine, Khyber Medical College, Peshawar, Pakistan.
Insights
Prothrombin complex concentrate (PCC) significantly reduces bleeding and red blood cell transfusions in cardiac surgery patients compared to fresh frozen plasma (FFP). PCC may also reduce acute kidney injury, supporting its selective use for managing bleeding.
Area of Science:
- Cardiology
- Hematology
- Critical Care Medicine
Background:
- Coagulopathy and bleeding are frequent complications after cardiac surgery.
- Hemostatic agents like prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP) are commonly used.
- Optimal agent selection for managing bleeding in this population remains a key clinical question.
Purpose of the Study:
- To systematically review and meta-analyze randomized controlled trials comparing PCC and FFP in adult cardiac surgery patients.
- To evaluate the efficacy and safety of PCC versus FFP in managing post-operative bleeding and coagulopathy.
- To assess the impact on transfusion requirements, clinical outcomes, and adverse events.
Main Methods:
- A comprehensive literature search was performed across PubMed, Embase, and Web of Science up to March 30, 2025.
- Included randomized controlled trials (RCTs) comparing PCC and FFP in adult cardiac surgery patients with bleeding or coagulopathy.
- Analyzed data from 4 RCTs involving 671 patients (PCC: 343; FFP: 328) focusing on primary and secondary outcomes.
Main Results:
- PCC significantly reduced chest tube output (mean difference = -162.12 mL, P = 0.002) and red blood cell (RBC) transfusion requirements (number of units and proportion of patients, P < 0.0001).
- No significant differences were observed in ICU/hospital length of stay, thromboembolic events, stroke/TIA, or 30-day mortality between groups.
- Sensitivity analysis indicated a potential benefit of PCC in reducing acute kidney injury.
Conclusions:
- Prothrombin complex concentrate demonstrates superior efficacy in reducing blood loss and transfusion needs compared to fresh frozen plasma in cardiac surgery.
- The safety profiles are comparable regarding major adverse events like thromboembolism and mortality.
- Findings support the selective administration of PCC for effective bleeding management in adult cardiac surgery patients.
Abstract:
Coagulopathy and bleeding are common complications following cardiac surgery, often requiring the use of hemostatic agents such as prothrombin complex concentrate (PCC) or fresh frozen plasma (FFP). This systematic review and meta-analysis compared the efficacy and safety of PCC versus FFP in adult patients undergoing cardiac surgery complicated by bleeding or coagulopathy. A comprehensive search of PubMed, Embase, and Web of Science was conducted from inception to March 30, 2025, identifying randomized controlled trials comparing these interventions. Primary outcomes included chest tube drainage within 24 hours, the number of red blood cell (RBC) units transfused, and the proportion of patients requiring RBC transfusion. Secondary outcomes were hospital and intensive care unit length of stay, the incidence of stroke or transient ischemic attack, thromboembolic events, acute kidney injury, and all-cause mortality within 30 days. Four randomized controlled trials, including 671 patients (PCC: 343; FFP: 328), were analyzed. PCC significantly reduced chest tube output [mean difference = -162.12 mL, 95% confidence interval (CI): -264.46 to -59.78, P = 0.002], number of RBC units transfused (mean difference = -0.93, 95% CI: -1.34 to -0.51, P < 0.0001), and proportion of patients requiring RBC transfusion (risk ratio = 0.81, 95% CI: 0.71-0.91, P = 0.0007). No significant differences were found in intensive care unit/hospital stay, thromboembolic events, stroke/transient ischemic attack, or mortality. Sensitivity analysis suggested a potential reduction in acute kidney injury with PCC. These findings support the selective use of PCC for bleeding management in cardiac surgery.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview

